Skip to content
‹ Back to IndustriesHealthcare

What led you to Benchmark Products

William Sepsis's path to Benchmark Products was influenced by a personal experience with in-home dialysis. This highlighted the significance of sterility assurance in healthcare. Benchmark Products is a leading supplier in the life sciences industry, known for its innovative solutions and trusted quality.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Benchmark Products on MarketScale.

By William Sepsis · · Healthcare MaterialsIn-home DialysisLife Sciences CareersMedical Manufacturing
Share

Key takeaways

01

William Sepsis's journey into life sciences was inspired by personal experience with in-home dialysis.

02

Sterility assurance is crucial in medical manufacturing and life-saving procedures.

03

Benchmark Products is a leading provider of life science manufacturing solutions.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

For many professionals, the path into life sciences isn’t sparked by spreadsheets or strategy decks, but by a deeply human moment that reveals how invisible systems quietly sustain life. Will Sepsis’s journey to Benchmark Products grew from witnessing a family member rely on in-home dialysis, an experience that exposed how sterility assurance—often overlooked outside the pharmaceutical world—can be the difference between survival and catastrophe. That personal realization underscores why Benchmark’s work matters: behind every sterile material and process is a chain of care that transforms technical precision into profoundly meaningful impact.

Benchmark Products

Part of this channel

Benchmark Products

ISO-certified cleanroom supplies for life science manufacturers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

William Sepsis
William SepsisBusiness Development Manager

As a Business Development Representative in the life sciences industry at Benchmark Products, Will specialize in helping companies achieve Annex 1 compliance and cGMP standards by addressing bioburden in cleanroom facilities. Our diverse product range includes pharmaceutical manufacturing supplies, cleaning materials, and cleanroom apparel. Benchmark Products offers advanced cleanroom technologies designed to enhance efficiency, quality, and cost-effectiveness, serving over 500 life science customers with tailored solutions. Our offerings support pharmaceutical manufacturing for sterile injectables, biopharmaceuticals, solid dose and HPAPIs, cell/gene therapies, radiopharmaceuticals, medical devices, and combination drug products.

B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

AI cuts cardiologists' echocardiogram review time by 46%

AI cuts cardiologists' echocardiogram review time by 46%

Late-breaking research presented November 9 at the American Heart Association's Scientific Sessions 2026 reported that AI-drafted preliminary echocardiogram reports were comparable to human drafts. Cardiologists averaged 4.6 minutes finalizing AI drafts versus 8.5 minutes without AI. The findings are a non-peer-reviewed abstract.

  • 01Cardiologists averaged 4.6 minutes finalizing AI-drafted echo reports versus 8.5 minutes without AI, about 46% less time.
  • 02Cardiologists made substantial changes to 50.6% of AI drafts and 49.7% of human drafts.
  • 03The research used 1,200 echocardiograms from 21 Kaiser Permanente Northern California medical centers.

Nov 9, 2026

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

At AHA Scientific Sessions 2026 in Chicago, AI ECHO INSIGHT, WATCH-LV, PARAMOUNT and PROVAR+ showed gains in workflow efficiency, screening and treatment decisions, but none established a reduction in hard clinical events. The takeaway: the next test is proving these tools improve outcomes, especially in high-need populations, by connecting to established care.

  • 01AI ECHO INSIGHT cut echo reads 8.5 to 4.6 minutes, and PARAMOUNT changed treatment decisions, but no AI late-breaker showed fewer hard events.
  • 02ZEUS and Lp(a)HORIZON lowered their target biomarkers without reducing major cardiovascular events, a caution against treating algorithmic accuracy alone as proof of patient benefit.
  • 03Low-technology, team-based interventions such as CATCH in Colombia and Jamaica lowered blood pressure, showing the care systems AI tools must connect to.

Nov 9, 2026

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Access TeleCare pharmacist Ashley Selby describes a telehealth antimicrobial stewardship model sized to each hospital's gaps. Joint Commission Standard MM.09.01.01 and 42 CFR 482.42 require a qualified physician and/or pharmacist leader, not a full-time hire, and a 14-study meta-analysis found telehealth stewardship cut antibiotic days of therapy without changing mortality.

  • 01Joint Commission Standard MM.09.01.01, in force since January 2023, requires a physician and/or pharmacist qualified in infectious diseases or stewardship to lead the program, and its committee note allows remote participation.
  • 02The Board of Pharmacy Specialties counts more than 2,380 BCIDP pharmacists nationally, while many small hospitals still assign stewardship to pharmacists without ID training.
  • 03A 14-study meta-analysis found telehealth stewardship raised guideline adherence and cut antibiotic days of therapy, but did not significantly change mortality.

Nov 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

William Sepsis
William Sepsis

Business Development Manager

William Sepsis is an expert in the field of life sciences and healthcare materials. His journey into the industry was inspired by witnessing a family member rely on in-home dialysis. This experience highlighted the critical importance of sterility assurance in life-saving medical procedures.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512